Pediatric applications of Dotatate: early diagnostic and therapeutic experience.
Children
Dotatate
Neuroendocrine tumor
Nuclear medicine imaging
Somatostatin receptor agents
Theranostics
Journal
Pediatric radiology
ISSN: 1432-1998
Titre abrégé: Pediatr Radiol
Pays: Germany
ID NLM: 0365332
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
20
01
2020
accepted:
22
04
2020
revised:
17
03
2020
pubmed:
5
6
2020
medline:
27
4
2021
entrez:
5
6
2020
Statut:
ppublish
Résumé
In recent years, new somatostatin receptor agents (SSTRs) have become available for diagnostic imaging and therapy in neuroendocrine tumors. The novel SSTR ligand DOTA-DPhel-Tyr3-octreotate (Dotatate) in particular can be linked with
Identifiants
pubmed: 32495176
doi: 10.1007/s00247-020-04688-z
pii: 10.1007/s00247-020-04688-z
doi:
Substances chimiques
Contrast Media
0
Organometallic Compounds
0
Radiopharmaceuticals
0
Receptors, Somatostatin
0
gallium Ga 68 dotatate
9L17Y0H71P
lutetium Lu 177 dotatate
AE221IM3BB
Octreotide
RWM8CCW8GP
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
882-897Commentaires et corrections
Type : CommentIn
Type : CommentIn